CTLA-4 (monomer)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c006/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c006/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c005/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c005/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c004/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c004/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c003/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c003/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c002/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c002/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c001/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c001/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9c000/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9c000/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfff/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfff/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bffe/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bffe/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bffc/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bffc/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bffb/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bffb/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bffa/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bffa/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff9/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff9/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff8/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff8/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff7/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff7/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff6/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff6/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff5/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff5/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff4/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff4/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff3/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff3/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff2/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff2/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff1/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff1/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bff0/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bff0/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfef/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfef/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfee/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfee/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfed/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfed/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfec/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfec/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfeb/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfeb/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfea/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfea/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe9/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe9/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe8/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe8/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe7/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe7/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe6/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe6/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe5/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe5/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe4/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe4/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe3/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe3/ctla-4-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc54030380d0028b9bfe2/ctla-4-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc54030380d0028b9bfe2/ctla-4-monomer.png"}]
Keywords
immune checkpoint,t-cell,T cell,APC,CD89,CD86,CTLA4,CTLA-4,CD152,cytotoxic t-lymphocyte associated 4,ALPS4,CELIAC3,GRD4,GSE,IDDM12